Maurice Zauderer Vaccinex's guest appearances

Maurice Zauderer Vaccinex

Empowered Patient Podcast

Mark Allen

David Katz

Rosalind Picard

David Solomon

Matt Murphy

Robin Smith

Thomas Cowan

Greg Miller

Travis Mickle

Justin Miller

Sean Tucker

Matt Wilson

Chris Young

Jim Martin

Robin Zander

OwlTail

Maurice Zauderer, CEO, Vaccinex discusses pepinemab, the antibody drug being developed by Vaccinex for treatment of Huntington's disease, Alzheimer's disease and lung cancer.  Maurice also touches on the relationship between neurodegenerative diseases and cancer, and the commonalities that allow for a treatment like pepinemab to have a potential benefit in both therapeutic areas. @vaccinex $VCNX #immunotherapy #rarediseases #cancer Vaccinex.com Download the transcript here

Maurice Zauderer, CEO, Vaccinex discusses pepinemab, the antibody drug being developed by Vaccinex for treatment of Huntington's disease, Alzheimer's disease and lung cancer.  Maurice also touches on the relationship between neurodegenerative diseases and cancer, and the commonalities that allow for a treatment like pepinemab to have a potential benefit in both therapeutic areas. @vaccinex $VCNX #immunotherapy #rarediseases #cancer <a href="http://www.vaccinex.com/" rel="noopener nofollow" target="_blank">Vaccinex.com</a> <a href="http://empoweredpatientradio.com/pepinemab-antibody-drug-in-development-for-neurodegenerative-diseases-with-maurice-zauderer-vaccinex-transcript" rel="noopener nofollow" target="_blank">Download the transcript here</a>

Pepinemab Antibody Drug in Development for Neurodegenerative Diseases with Maurice Zauderer Vaccinex